Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

NCT06665646 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: CD40.HIVRI.Env (VRIPRO)
BIOLOGICAL: Hiltonol Poly-ICLC-adjuvant

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)